Man Group’s Biohaven BHVN Stock Holding History

Man Group’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63,407	Closed	-$895K	–	2219
2025 Q2	$895K	Buy	+63,407	New	+$1.13M	﹤0.01%	1657

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Man Group's BHVN Position: Q3 2025 in Review

Man Group sold out of Biohaven (BHVN) in Q3 2025, closing a stake of 63,407 shares — an estimated $895K sold.

Man Group first reported a position in BHVN in Q2 2025 and held it in 1 quarter. The position peaked at $895K in Q2 2025. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

Man Group reported no remaining Biohaven position as of Q3 2025 after selling out during the quarter.
Man Group sold 63,407 Biohaven shares in Q3 2025, an estimated $895K.
Man Group first reported a position in Biohaven in Q2 2025 and held it in 1 quarter.
Man Group's Biohaven position peaked at $895K in Q2 2025.
264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.